The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Cyclophosphamide versus placebo in scleroderma lung disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D. E., Arriola, E., Silver, R., Strange, C., Bolster, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055120 · Cited by 1,677
Self-citationChannick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
SIMONNEAU, G., BARST, R. J., GALIE, N., NAEIJE, R., RICH, S., BOURGE, R. C., KEOGH, A., OUDIZ, R., FROST, A., BLACKBURN, S. D., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2106079 · Cited by 1,441
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
Sitbon, O., Humbert, M., Nunes, H., Parent, F., Garcia, G., Hervé, P., Rainisio, M., & Simonneau, G. É. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02012-0 · Cited by 1,383
Clinical guidelines: Developing guidelines
Shekelle, P. G., Woolf, S. H., Eccles, M., & Grimshaw, J. (1999) · BMJ · doi:10.1136/bmj.318.7183.593 · Cited by 1,222
Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy
McLaughlin, V. V., Shillington, A., & Rich, S. (2002) · Circulation · doi:10.1161/01.cir.0000029100.82385.58 · Cited by 1,213
Badesch, D. B., Tapson, V. F., McGoon, M. D., Brundage, B. H., Rubin, L. J., Wigley, F. M., Rich, S., Barst, R. J., Barrett, P. S., Kral, K. M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00002 · Cited by 1,075
Self-citationChiba, N., De Gara, C., Wilkinson, J., & Hunt, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178669 · Cited by 857
Medical Therapy For Pulmonary Arterial Hypertension
Badesch, D. B., Abman, S. H., Ahearn, G. S., Barst, R. J., McCrory, D. C., Simonneau, G., & McLaughlin, V. V. (2004) · Chest · doi:10.1378/chest.126.1_suppl.35s · Cited by 829
Hoyles, R. K., Ellis, R. W., Wellsbury, J., Lees, B., Newlands, P., Goh, N. S. L., Roberts, C., Desai, S., Herrick, A. L., McHugh, N. J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22204 · Cited by 732
Self-citationKorn, J. H., Mayes, M., Matucci Cerinic, M., Rainisio, M., Pope, J., Hachulla, E., Rich, E., Carpentier, P., Molitor, J., Seibold, J. R., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20676 · Cited by 728
Self-citationSitaxsentan Therapy for Pulmonary Arterial Hypertension
Barst, R. J., Langleben, D., Frost, A., Horn, E. M., Oudiz, R., Shapiro, S., McLaughlin, V., Hill, N., Tapson, V. F., Robbins, I. M., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-957oc · Cited by 706
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
Humbert, M., Barst, R. J., Robbins, I. M., Channick, R. N., Galiè, N., Boonstra, A., Rubin, L. J., Horn, E. M., Manes, A., & Simonneau, G. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00028404 · Cited by 640
Sigterman, K. E., van Pinxteren, B., Bonis, P. A., Lau, J., & Numans, M. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002095.pub5 · Cited by 507
Barst, R. J., Langleben, D., Badesch, D., Frost, A., Lawrence, E. C., Shapiro, S., Naeije, R., & Galie, N. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.057 · Cited by 478
Felson, D. T., Anderson, J. J., Lange, M. L. M., Wells, G., & LaValley, M. P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 474
Steen, V. D., Costantino, J. P., Shapiro, A. P., & Medsger, T. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-5-352 · Cited by 441
Medical Therapy for Pulmonary Arterial Hypertension
Badesch, D. B., Abman, S. H., Simonneau, G., Rubin, L. J., & McLaughlin, V. V. (2007) · Chest · doi:10.1378/chest.06-2674 · Cited by 438
Wigley, F. M., Wise, R. A., Seibold, J. R., McCloskey, D. A., Kujala, G., Medsger, T. A., Steen, V. D., Varga, J., Jimenez, S., Mayes, M., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00004 · Cited by 421
Self-citationEffect of Octreotide on Intestinal Motility and Bacterial Overgrowth in Scleroderma
Soudah, H. C., Hasler, W. L., & Owyang, C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252102 · Cited by 414
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study
Wilkins, M. R., Paul, G. A., Strange, J. W., Tunariu, N., Gin-Sing, W., Banya, W. A., Westwood, M. A., Stefanidis, A., Ng, L. L., Pennell, D. J., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1411oc · Cited by 380
Galiè, N., Hinderliter, A. L., Torbicki, A., Fourme, T., Simonneau, G., Pulido, T., Espinola-Zavaleta, N., Rocchi, G., Manes, A., Frantz, R., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00121-9 · Cited by 378
VAN DEN HOOGEN, F. H. J., BOERBOOMS, A. M. T., SWAAK, A. J. G., RASKER, J. J., VAN LIER, H. J. J., & VAN DE PUTTE, L. B. A. (1996) · Rheumatology · doi:10.1093/rheumatology/35.4.364 · Cited by 355
Self-citationLong-Term Outcomes of Scleroderma Renal Crisis
Steen, V. D., & Medsger, T. A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00010 · Cited by 321
Dziadzio, M., Denton, C. P., Smith, R., Howell, K., Blann, A., Bowers, E., & Black, C. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199912)42:12<2646::aid-anr21>3.0.co;2-t · Cited by 318
Self-citationCalcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
Thompson, A. E., Shea, B., Welch, V., Fenlon, D., & Pope, J. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)44:8<1841::aid-art322>3.0.co;2-8 · Cited by 290
Oudiz, R. J., Schilz, R. J., Barst, R. J., Galié, N., Rich, S., Rubin, L. J., & Simonneau, G. (2004) · Chest · doi:10.1378/chest.126.2.420 · Cited by 264
Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's Phenomenon
Rodeheffer, R. J., Rommer, J. A., Wigley, F., & Smith, C. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304143081507 · Cited by 242
Self-citationSystemic sclerosis associated pulmonary hypertension: improved survival in the current era
Williams, M. H. (2006) · Heart · doi:10.1136/hrt.2005.069484 · Cited by 237
Rademaker, M., Cooke, E. D., Almond, N. E., Beacham, J. A., Smith, R. E., Mant, T. G., & Kirby, J. D. (1989) · BMJ · doi:10.1136/bmj.298.6673.561 · Cited by 231
DeMarco, P. J., Weisman, M. H., Seibold, J. R., Furst, D. E., Wong, W. K., Hurwitz, E. L., Mayes, M., White, B., Wigley, F., Barr, W., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10589 · Cited by 225
Self-citationWigley, F. M., Seibold, J. R., Wise, R. A., McCloskey, D., & Dole, W. P. (1992) · PubMed · Cited by 221
Self-citationNormotensive renal failure in systemic sclerosis
Helfrich, D. J., Banner, B., Steen, V. D., & Medsger, T. A. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320911 · Cited by 217
Dougados, M., Betteridge, N., Burmester, G. R., Euller-Ziegler, L., Guillemin, F., Hirvonen, J., Lloyd, J., Ozen, S., Da Silva, J. A. P., Emery, P., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023697 · Cited by 214
Self-citationReversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme Blockade
Lopez-Ovejero, J. A., Saal, S. D., D'Angelo, W. A., Cheigh, J. S., Stenzel, K. H., & Laragh, J. H. (1979) · New England Journal of Medicine · doi:10.1056/nejm197906213002505 · Cited by 207
Wigley, F. M., Korn, J. H., Csuka, M. E., Medsger, T. A., Rothfield, N. F., Ellman, M., Martin, R., Collier, D. H., Weinstein, A., Furst, D. E., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199804)41:4<670::aid-art14>3.0.co;2-i · Cited by 203
Self-citationVerne, G. N., Eaker, E. Y., Hardy, E., & Sninsky, C. A. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02208652 · Cited by 185
Endothelin receptor antagonists for pulmonary arterial hypertension
Liu, C., Chen, J., Gao, Y., Deng, B., & Liu, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004434.pub5 · Cited by 181
Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis
Pope, J., Fenlon, D., Thompson, A., Shea, B., Furst, D., Wells, G. A., & Silman, A. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000953 · Cited by 180
Self-citationBosentan therapy for pulmonary arterial hypertension
Rubin, L. J., Badesch, D. B., & Barst, R. J. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00782-1 · Cited by 176
Scorza, R., Caronni, M., Mascagni, B., Berruti, V., Bazzi, S., Micallef, E., Arpaia, G., Sardina, M., Origgi, L., & VANOLI, M. (2001) · PubMed · Cited by 175
Small Intestinal Bacterial Overgrowth: Diagnosis and Treatment
Gasbarrini, A., Lauritano, E. C., Gabrielli, M., Scarpellini, E., Lupascu, A., Ojetti, V., & Gasbarrini, G. (2007) · Digestive Diseases · doi:10.1159/000103892 · Cited by 159
Immunosuppressive and Cytotoxic Pharmacotherapy for Pulmonary Disorders
Lynch, J. P., & McCune, W. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032171 · Cited by 153
Black, C. M., Halkier-Sørensen, L., Belch, J. J. F., Ullman, S., Madhok, R., Smit, A. J., Banga, J. D., & Watson, H. R. (1998) · Rheumatology · doi:10.1093/rheumatology/37.9.952 · Cited by 139
Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis
Horowitz, M., Maddern, G. J., Maddox, A. F., Wishart, J. M., Chatterton, B. E., & Shearman, D. J. C. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)91020-1 · Cited by 128
McHugh, N. J., Csuka, M. E., Watson, H. R., Belcher, G., Amadi, A. A., Ring, E. F. J., Black, C. M., & Maddison, P. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.1.43 · Cited by 102
Survival in patients with pulmonary arterial hypertension treated with first‐line bosentan
McLaughlin, V. V. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01688.x · Cited by 97
A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
Kahan, A., Amor, B., & Menkes, C. J. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.1.30 · Cited by 81
Belch, J. J. F., Capell, H. A., Cooke, E. D., Kirby, J. D. T., Lau, C. S., Madhok, R., Murphy, E., & Steinberg, M. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.3.197 · Cited by 77
SUCCESSFUL TREATMENT OF RAYNAUD'S SYNDROME WITH ILOPROST, A CHEMICALLY STABLE PROSTACYCLIN ANALOGUE
Yardumian, D., Isenberg, D. A., Rustin, M. H. A., Belcher, G., Snaith, M. L., Dowd, P. M., & Machin, S. J. (1988) · Rheumatology · doi:10.1093/rheumatology/27.3.220 · Cited by 73
Promotility Medications – Now and in the Future
Karamanolis, G., & Tack, J. F. (2006) · Digestive Diseases · doi:10.1159/000092883 · Cited by 67
Kyle, M. V., Belcher, G., & Hazleman, B. L. (1992) · PubMed · Cited by 67
Sitaxsentan Treatment for Patients With Pulmonary Arterial Hypertension Discontinuing Bosentan
Benza, R. L., Mehta, S., KEOGH, A. M., Lawrence, E. C., Oudiz, R. J., & Barst, R. J. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.10.019 · Cited by 65
Avouac, J., Kowal‐Bielecka, O., Landewé, R., Chwieśko-Minarowska, S., Miniati, I., Czirják, L., Clements, P. J., Denton, C. P., Farge, D., Fligelstone, K., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.095299 · Cited by 64
Self-citationNifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis
THOMAS, R. H. M., Rademaker, M., GRIMES, S. M., Mackay, A. R., Kovács, I. B., Cook, E., Bowcock, S., & Kirby, J. D. T. (1987) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1987.tb04122.x · Cited by 60
Fiorucci, S., Distrutti, E., Gerli, R., & Morelli, A. (1994) · PubMed · Cited by 58
Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon
Ettinger, W. H., Wise, R. A., Schaffhauser, D., & Wigley, F. M. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90101-3 · Cited by 58
Self-citationKahan, A., Chaussade, S., Gaudric, M., Freitag, B., Amor, B., Menkes, C. J., Strauch, G., Guerre, J., & Couturier, D. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05593.x · Cited by 55
Endothelin receptor antagonists for pulmonary arterial hypertension
Liu, C., Chen, J., Gao, Y., Deng, B., & Liu, K. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004434.pub6 · Cited by 51
Lau, C. S., Belch, J. J. F., Madhok, R., Cappell, H., Herrick, A. L., Jayson, M. I. V., & Thompson, J. (1993) · PubMed · Cited by 45
Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon)
Kahan, A., Weber, S., Amor, B., Menkes, C. J., Saporta, L., Hodara, M., Guerin, F., & Degeorges, M. (1983) · European Heart Journal · doi:10.1093/eurheartj/4.suppl_c.123 · Cited by 40
Wang, S.-J., Lan, J.-L., Lan, J.-L., Chen, D.-Y., Chen, Y.-H., Hsieh, T., & Lin, W.-Y. (2002) · Clinical Rheumatology · doi:10.1007/s100670200010 · Cited by 37
Pharmacotherapy for intestinal motor and sensory disorders
Hasler, W. L. (2003) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(03)00027-x · Cited by 36
Nifedipine and alpha1-adrenergic blockade in Raynaud‘s phenomenon
Kahan, A., Foult, J., Weber, S., Amor, B., Menkes, C. J., & Degeorges, M. (1985) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061923 · Cited by 32
Nicardipine in the Treatment of Raynaud's Phenomenon: A Randomized Double-Blind Trial
Kahan, A., Amor, B., Menkes, C. J., Weber, S., Guérin, F., & Degeorges, M. (1987) · Angiology · doi:10.1177/000331978703800407 · Cited by 31
Cyclophosphamide versus Placebo in Scleroderma Lung Disease
Hayat, S. Q. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70023-3 · Cited by 29
Limburg, A. J., Smit, A. J., & Kleibeuker, J. H. (2009) · Digestion · doi:10.1159/000200715 · Cited by 26
Wehrmann, T., & Caspary, W. F. (1990) · Journal of Molecular Medicine · doi:10.1007/bf01660958 · Cited by 26
Long-Term Outcomes of Scleroderma Renal Crisis
(2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00005 · Cited by 19
Pope (2001) · doi:10.1002/1529-0131(200106)44:6<1351::aid-art227>3.0.co;2-i
Cited by
Update of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
Self-citation2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
Braun, J., van den Berg, R., Baraliakos, X., Boehm, H., Burgos-Vargas, R., Collantes-Estevez, E., Dagfinrud, H., Dijkmans, B., Dougados, M., Emery, P., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.151027 · Cited by 987
Khanna, D., Denton, C. P., Jahreis, A., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00232-4 · Cited by 683
Self-citationElhai, M., Meune, C., Avouac, J., Kahan, A., & Allanore, Y. (2012) · Rheumatology · doi:10.1093/rheumatology/ker269 · Cited by 460
Self-citationMeier, F. M. P., Frommer, K. W., Dinser, R., Walker, U. A., Czirjak, L., Denton, C. P., Allanore, Y., Distler, O., Riemekasten, G., Valentini, G., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200742 · Cited by 367
Self-citation
Metadata
- Authors
- Kowal-Bielecka, O., Landewé, R., Avouac, J., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., Földvari, I., Furst, D. E., Müller-Ladner, U., Seibold, J., Silver, R. M., Takehara, K., Toth, B. G., Tyndall, A., Valentini, G., van den Hoogen, F., Wigley, F., Zulian, F., & Matucci-Cerinic, M.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 68
- Issue
- 5
- Pages
- 620-628
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2138183967
- Cited by
- 619
- References
- 75
- FWCI
- 32.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.